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Methionine adenosyltransferase is a ubiquitous en-
zyme that catalyzes the only known route of biosynthe-
sis of S-adenosylmethionine, the major methyl group
donor in cell metabolism. In mammals, two different
methionine adenosyltransferases exist: one is confined
to the liver, and the other one is distributed in extrahe-
patic tissues. In the present study, we report the cloning
of the 5*-flanking region of liver-specific methionine ad-
enosyltransferase gene from rat. Two closely spaced
sites for transcriptional initiation were identified by
primer extension analysis. The major transcription start
site was determined to be 29 nucleotides downstream
from the putative TATA box. Transient transfection as-
says of constructs containing sequentially deleted 5*-
flanking sequences fused to the luciferase gene showed
that rat hepatic methionine adenosyltransferase pro-
moter was able to efficiently drive reporter expression
not only in liver-type cells (rat hepatoma H35 cells and
human hepatoblastoma HepG2 cells) but also in Chinese
hamster ovary cells. Two regions spanning nucleotides
21251 to 2958 and 2197 to 165 were found to be crucial
for the promoter efficiency. The distal upstream region
contains elements that positively regulate promoter ac-
tivity in H35 and HepG2 cells but are ineffective in Chi-
nese hamster ovary cells. Eight protein binding sites
were characterized in both regions by DNase I footprint-
ing analysis. Two of these elements, sites A and B, lo-
cated in the distal region, were found to be essential for
the regulation of promoter activity. Electrophoretic mo-
bility shift assays and competition experiments showed
that site A is recognized by an NF1 protein. Site B was
able to interact with a member of HNF-3 family when
nuclear extracts from rat liver and H35 cells were used
in the in vitro assay, but an additional binding activity
to an NHF1-like protein was obtained with the hepa-
toma cell extracts. It is suggested that this differential
binding can contribute to the cell specificity of pro-
moter function.
S-Adenosylmethionine plays a central role in cellular metab-
olism, being the major methyl group donor in transmethylation
reactions and the source of propylamine moieties for polyamine
biosynthesis (1, 2). S-Adenosylmethionine is synthesized by
transfer of the adenosyl moiety from ATP to the sulfur atom of
methionine, in a reaction catalyzed by the enzyme methionine
adenosyltransferase (MAT1; ATP:L-methionine S-adenosyl-
transferase, EC 2.5.1.6) (3). The occurrence of MAT has been
extensively studied in a variety of organisms, where different
isoenzyme forms have been characterized (2). In mammals,
biochemical and molecular cloning studies have revealed the
existence of at least two MAT (for a consensus nomenclature for
mammalian methionine adenosyltransferase genes and gene
products, see Ref. 4). One is selectively expressed in the liver
and the other one is distributed in non-hepatic tissues (re-
viewed in Ref. 5). The presence of a liver-specific isoenzyme is
related to the main role of this organ in methionine metabo-
lism. Thus, most of the methionine taken up from the diet is
metabolized in the liver, and up to 85% of all transmethylation
reactions occur in the liver (5).
Hepatic MAT is a cytosolic homo-oligomeric protein, found as
a mixture of tetramers and dimers (6, 7). Its expression corre-
lates well with liver growth and differentiation, having been
proposed to be a marker of the differentiated state of the
hepatocyte (8). There is growing evidence suggesting that this
enzyme can be regulated at different levels by a variety of
factors and under several pathological conditions. For instance,
a serious decrease in the enzyme activity, without a concomi-
tant reduction in the expression of the gene, has been found in
several human hepatic disorders (9, 10), as well as in different
experimental models of liver injury (11, 12). In contrast, a
marked reduction of MAT gene expression has been reported in
human hepatocarcinoma (13) and in a rat model of hypoxia-
induced liver injury (14). On the other hand, glucocorticoids
(15) and cAMP (8) increase the expression of the gene in rats,
whereas insulin blocks the inducing effect of glucocorticoids (8).
Altogether, these results suggest that hepatic MAT gene ex-
pression is regulated differently under various normal and
pathophysiological conditions. The necessity of a strict regula-
tion of the expression of this enzyme has been recently empha-
sized by the fact that a sustained enhancement in its synthesis
is accompanied by a depletion of cellular ATP and NAD, and a
greater sensitivity to oxidative cell injury (16).
To study molecular mechanisms underlying the regulation of
hepatic MAT expression, we have isolated and characterized
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the 59-flanking region of the rat MAT gene. The regulatory
elements necessary for basal expression have been identified
using transient transfections into various cell lines with he-
patic MAT promoter-luciferase chimeric genes as well as by in
vitro DNase I footprinting analysis. These cis-acting elements
are clustered in a promoter proximal region and in a distal
region. We finally show that transcriptional activity of hepatic
MAT promoter is predominantly dependent on the binding of
an NF1-like protein and liver-enriched transcription factors to
the promoter distal region.
EXPERIMENTAL PROCEDURES
General Procedures—Standard procedures were used for screening
the recombinant genomic library, restriction enzyme mapping, subclon-
ing, DNA labeling, isolation of genomic DNA, Southern transfer, and
hybridization to DNA on filters (17, 18). Oligonucleotide primers were
synthesized on an Applied Biosystems 391 DNA synthesizer using the
phosphoramidite method.
Isolation and Characterization of Genomic Clones—A rat genomic
DNA library in EMBL-3 SP6/T7 (CLONTECH) was screened using as a
probe a 32P-labeled 580-bp EcoRI/XbaI fragment of the pSSRL cDNA
clone (19), which contains 211 bp of the 59-untranslated sequence and
the first 369 bp of the rat liver MAT coding region. Five overlapping
clones ranging in size between 13 and 18 kb kilobase pairs were isolated
from ;1 3 106 recombinants. Clones were plaque-purified and sub-
jected to Southern analysis. Fragments of interest were subcloned into
the plasmid pUC18. DNA was sequenced on both strands by the dideoxy
termination method (20), using Sequenase (U. S. Biochemical Corp.)
and either pUC/M13 forward and reverse primers or sequence-specific
oligonucleotide primers.
Primer Extension Analysis—Poly(A)1 RNA used for primer extension
studies was prepared from rat liver by oligo(dT)-cellulose chromatogra-
phy (21). A 24-base oligonucleotide primer complementary to nucleo-
tides 2186/2163 of the rat liver MAT cDNA (19) was end-labeled with
[g-32P]ATP using T4 polynucleotide kinase. Three mg of rat liver
poly(A)1 RNA (or yeast tRNA as negative control) were annealed to 106
cpm of the primer and extended with 200 units of Moloney murine
leukemia virus reverse transcriptase (Superscript II, Life Technologies,
Inc.) as described previously (19). The primer-extended products were
analyzed on 7 M urea, 6% polyacrylamide gels, in parallel with sequenc-
ing reactions carried out on the genomic subclone using the same
primer.
Construction of Promoter-Luciferase Fusion Vectors—Eleven deletion
constructs of different length were generated by PCR, using a MAT
genomic clone as template. Initially, a DNA fragment spanning 1470 bp
of the 59-flanking region was amplified using 39 and 59 primers corre-
sponding to nucleotides 149 to 165 and 21405 to 21389, respectively.
The purified PCR product was inserted into the SmaI site of pUC18
plasmid. Ten deletions were then constructed by inverse PCR (22),
using a vector-specific 59 primer and 39 primers complementary to
nucleotides 21251 to 21235, 21154 to 21133, 21134 to 21118, 21080
to 21064, 2958 to 2942, 2727 to 2711, 2527 to 2511, 2375 to 2359,
2193 to 2177, and 287 to 271 of the cloned sequence. PCR reactions
were performed as described previously (7) but using the thermostable
DNA polymerase Dynazyme (Finnzymes Oy, Finland). The inserts of
these 11 constructs were digested with KpnI and SalI and subcloned
into the corresponding sites of the luciferase promoterless vector pXP1
(23). The identity of the constructs was confirmed by sequencing.
Transient Transfection Analysis—The relative transcriptional activ-
ities of MAT promoter fragments were determined by transient trans-
fection analysis in cultured H35, HepG2, and CHO cells. Typically, cells
were cultured in Dulbecco’s modified Eagle’s medium supplemented
with 10% fetal calf serum and plated at approximately 3 3 105 cells/
60-mm culture dish 24 h before transfections. The cells were transfected
by the calcium phosphate precipitation method (18) with 6 mg (CHO) or
15 mg (H35, HepG2) of each DNA construct. Five mg of the b-galacto-
sidase expression vector pCH110 (Pharmacia Biotech) were included as
an internal standard of transfection efficiency.
After 18 h, the DNA precipitates were rinsed twice with phosphate-
buffered saline, and cells were further grown for 24 h in culture me-
dium. The cells were harvested in reporter lysis buffer (Promega),
following the manufacturer’s instructions, and the lysate was spun in a
microcentrifuge for 15 s. Luciferase and b-galactosidase activities were
determined as described (17, 18). All transfections were conducted in
triplicate using at least two different batches of each construct. Activ-
ities reported are averaged from three independent experiments.
Preparation of Nuclear Extracts—Nuclear extracts from rat tissues
or rat hepatoma H35 cells were prepared as described by Gorski et al.
(24) and Andrews and Faller (25), respectively. The final nuclear sus-
pension buffer contained 20 mM HEPES, pH 7.9, 0.4 M KCl, 0.2 mM
EDTA, 1.5 mM MgCl2, 1 mM dithiothreitol, 0.2 mM phenylmethylsulfo-
nyl fluoride, 0.5 mg/ml leupeptin, 10 mg/ml soybean trypsin inhibitor,
and 25% glycerol. Nuclear extracts were aliquoted and frozen at
270 °C. Protein concentrations were determined by the Bradford pro-
tein assay kit (Bio-Rad).
DNase I Footprinting Analysis—Two 32P-end-labeled fragments of
the 59-flanking region of rat liver MAT gene were generated by PCR
amplification of the template GSR4. The primers for these two frag-
FIG. 1. Southern blot analysis of rat genomic DNA. High molec-
ular mass genomic DNA from rat liver (10 mg per lane; right panel) and
DNA from clone GRS4 (1 mg per lane; left panel) were digested with
EcoRI, BamHI, XhoI, or PstI as indicated, separated on 1.2% agarose
gel, and transferred to a nylon membrane. The radiolabeled probe was
a 580-bp EcoRI/XbaI fragment of the rat liver MAT cDNA clone. lgt11
phage DNA digested with EcoRI and HindIII was used as a size marker;
molecular sizes are indicated.
FIG. 2. Determination of the transcription start site(s) of the
rat liver MAT gene by primer extension. A 32P-end-labeled primer
complementary to nucleotides 2186/2163 of the rat liver MAT cDNA
was annealed to rat liver poly(A)1 RNA (lane 1) or yeast tRNA (lane 2)
and extended with reverse transcriptase. The primer extended products
were analyzed on 6% denaturing polyacrylamide gels, in parallel with
sequencing reactions (GATC) carried out on the genomic subclone using
the same primer. Arrowheads show the position of the extended prod-
ucts. Solid circles indicate the position of the putative TATA box. The
sequences of the sense strand near the bands and the TATA box are
shown below.
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ments were 149 to 165, 2193 to 2177, 21012 to 2996, and 21251 to
21235. One primer from each pair was 59-end-labeled with [g-32P]ATP
using T4 polynucleotide kinase. PCR reactions were performed as de-
scribed (7). Amplified fragments were purified using Sephacryl S-300
columns (Pharmacia). Approximately 5 3 104 cpm of end-labeled DNA
fragments were incubated with 10–50 mg of nuclear proteins from rat
liver. After 30 min incubation at room temperature, CaCl2 and MgCl2
were added to give a final concentration of 0.5 and 1 mM, respectively.
DNase I digestions were performed at room temperature for 1 min,
using different amounts of enzyme. The reactions were stopped by the
addition of 140 ml of stop solution containing 2 mg of yeast tRNA, 20 mM
EDTA, 150 mM sodium acetate, and 1.5 mg of proteinase K. Upon phenol
extraction and ethanol precipitation, pellets were resuspended in sam-
ple dye buffer, and DNA fragments were resolved by electrophoresis in
a denaturing 8% acrylamide/urea sequencing gel. The positions of spe-
cific DNase I-protected regions were determined by sequencing the
fragments according to Maxam-Gilbert (26).
Electrophoretic Mobility Shift Assay—Electrophoretic mobility shift
assays were performed in a 20-ml binding reaction containing 5 mg of
crude nuclear extract, 40 mM HEPES, pH 7.5, 40 mM KCl, 0.2 mM
EDTA, 5 mM MgCl2, 1.25% Ficoll, 1 mg poly(dI-dC)zpoly(dI-dC), 1 mg of
sonicated herring sperm DNA, and, when indicated, a 50-fold molar
excess of competitor oligonucleotide. The reaction mixtures were incu-
bated on ice for 10 min, and then 6 3 104 cpm of annealed oligonucleo-
tides were added, and incubation was continued for an additional 30
min. The DNA-protein complexes were resolved in a 6% acrylamide gel
in 0.5 3 TBE (1 3 TBE: 89 mM Tris, pH 8.0, 89 mM boric acid, 2 mM
EDTA). Double-stranded oligonucleotides used as probes or competitors
were composed of the following sequences (top strand shown): MAT
promoter FPA site, CACTAGAATTTGTGCCAGAAAAAAAAAAAGTA;
FPB site, TGAACGTATTGATTAACTCACC; a mutant sequence (low-
ercase) of FPB site, oligonucleotide MtFPB, TGAACGcgTaGccTA-
ACTCA; the HNF-1 binding site from the rat albumin promoter, TGT-
GGTTAATGATCTACAGT (27); the HNF-3 binding site from the
transthyretin (TTR) promoter, GTTGACTAAGTCAATAATCAGAAT-
CAG (28); a C/EBP binding site, GGTATGATTTTGTAATGGGGTA
(29); a consensus NF-1 binding sequence, GCTTTGGCATGCTGC-
CAATATG (30); a consensus AP1 recognition site, ATTCTAGACT-
GAGTCATGGTACCGA (31).
RESULTS
Molecular Cloning of the 59-Flanking Region of Rat Liver
MAT Gene—A rat genomic DNA library in EMBL-3 sp6/T7 was
screened with a 580-bp EcoRI/XbaI fragment of the rat liver
MAT cDNA clone pSSRL, which comprises 211 bp of the 59-
untranslated sequence and the first 369 bp of the coding region
(19). Five overlapping clones containing inserts ranging in size
between 13 and 18 kb were isolated from approximately 1 3
106 recombinants. Restriction mapping and Southern analysis
showed that all of them contained different lengths of the
59-flanking region. A genomic clone of about 16 kb, designated
GRS4, containing approximately 6 kb of the 59-flanking region
of the MAT gene was chosen for detailed analysis. To verify
that no gross rearrangements had occurred during the cloning
process, Southern blots prepared with rat genomic DNA di-
gested with selected restriction endonucleases were hybridized
with the same probe used for screening the genomic library.
The sizes of the hybridizable fragments were identical to those
obtained when Southern analysis of the genomic clone GRS4
was performed under the same conditions (Fig. 1). These re-
FIG. 3. Nucleotide sequence and pu-
tative regulatory elements of the 5*-
flanking region of rat liver MAT
gene. Sequence is numbered relative to
the major transcription start site, which
is designated as 11. The minor start site
is marked with an asterisk. The putative
regulatory elements are indicated in bold
letters above the underlined sequences.
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sults indicate that the cloned DNA segment retains the same
sequence organization as in the genomic DNA and suggest that
hepatic MAT gene is present as a single copy in the rat genome.
Determination of the Transcriptional Start Sites—To deter-
mine the start site of transcription, a primer extension assay
was performed using poly(A)1 RNA from rat liver, as described
under “Experimental Procedures.” As shown in Fig. 2, a major
product corresponding to a 89-base extended fragment was
detected as well as a minor product two nucleotides longer.
These products were not detected when the assay was carried
out using tRNA. Sequencing reactions performed on the
genomic clone GRS4 using the same primer localized the major
start site 251 nucleotides from the ATG translation initiation
codon and 41 nucleotides upstream of the 59-end of the partial
cDNA sequence previously published (19). This base was des-
ignated as 11 for numbering the nucleotides in the gene.
Structural Features of the 59-Flanking Region—The nucleo-
tide sequence of rat hepatic MAT promoter region extending to
1557 bp upstream of the transcription initiation site is shown
in Fig. 3. The exon sequence corresponding to the first 41
nucleotides of the MAT mRNA, not present in the reported
cDNA sequence (19), is also included.
The 59-flanking region shares 88% sequence identity with
the 1113-bp promoter region reported for the mouse MAT gene
(32). Sequence analysis revealed a putative TATA box located
at positions 229 to 223, which is in agreement with the pre-
ferred position occupied by this element in a typical eukaryotic
promoter (33). The canonical CAAT box, usually present
around 280 bp, was not found in this area, but two perfect
CAAT motifs were located far away (positions 2379 and
21514). A number of DNA consensus sequences reported to
bind specific trans-acting factors were also present. Thus, two
AP-1 binding sites (34, 35) were found at positions 21057 to
21051 and 2294 to 2288. Two copies of the PEA3 motif (59-
AGGAAG-39) (36), an oncogene-, growth factor-, and phorbol
ester-responsive element, were located at 2772 to 2767 and
2217 to 2212. The consensus recognition motif for the glu-
cocorticoid response element (TGT(C/T)CT) (37) was repre-
sented 4 times at positions 2701 to 2696, 2636 to 2631, 2442
to 2437, and 266 to 261. Two interleukin-6 response elements
(38), which act as positive elements in several acute phase
protein genes, were identified at 21301 to 21296, in reverse
complement form, and at 2317 to 2312. Two NF-1 binding
motifs (59-TGGN7CCA-39) (39) were found at 21218 to 21206
and 2630 to 2618, the latter overlapping with a glucocorticoid
response element. Finally, the analysis also revealed several
DNA elements that matched the consensus binding sequences
for liver-enriched transcription factors, such as HNF-1 (27) (at
21144 to 21138), HNF-3 (40) (at 21128 to 1122 and 2581 to
2575), and HNF-4 (41) (at 2159 to 2154 and 279 to 273).
Functional Analysis of the 59-Flanking Region of Rat Liver
MAT Gene—To delineate the sequences that drive MAT expres-
sion, a series of deletion mutants extending from 21405 to 165
bp was generated by PCR and cloned into the promoterless
luciferase expression vector pXP1 (Fig. 4A). A similar plasmid
containing the RSV promoter was used as a positive control for
transfection. These chimeric constructs were transiently trans-
fected into two cell types of liver origin, the rat hepatoma H35
cell line and the human hepatoblastoma HepG2 cell line, as
well as into CHO cells. In all transfection experiments, a vector
expressing b-galactosidase was included as internal control.
Transient expression of luciferase activity showed that the
MAT-luciferase vectors were expressed in the three cell types.
The pattern of transcriptional activity of the chimeric con-
structs was very similar in H35 and HepG2 cells (Fig. 4B). Only
background expression was observed following transfection
FIG. 4. Transient transfection analyses of the rat liver MAT
promoter/luciferase constructs. A, schematic representation of the
hepatic MAT-luciferase chimeric constructs. Progressive 59 deletions of
the MAT promoter extending from 21405 to 165 bp were generated by
PCR (see “Experimental Procedures”) and fused to the promoterless
luciferase expression vector pXP1. Numbering is defined relative to the
major transcriptional start site. B and C, graphical presentation of the
transient luciferase activity in H35 (filled bars) and HepG2 cells
(hatched bars) (B) and CHO (C) cells, transfected with the chimeric
constructs described in A. Luciferase activities, normalized for b-galac-
tosidase expression, are presented as a percentage of the activity of the
21405/165 construct. The pXP1 vector without any promoter was used
as negative control. Transfections with the positive control plasmid
RSV-Luc were simultaneously performed (inset in B). The data repre-
sent the mean 6 S.E. from three independent experiments performed in
duplicate.
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with the pXP1 luciferase vector without any promoter frag-
ment. The highest luciferase activity, almost 14 and 20% of
RSV-luciferase activity in H35 and HepG2, respectively, was
observed with the 21405/165 construct. Removal of the frag-
ment 21405 to 21251 had little effect on the promoter effi-
ciency. However, successive 59 deletions from 21251 to 287 bp
resulted in a marked decrease in luciferase activity, indicating
the presence of a positive-acting region between 21251 and
2958, that increases transcriptional activity about 3-fold. De-
letions of sequences from 2958 to 2727, 2727 to 2527, 2527 to
2375, and 2375 to 2193 did not significantly affect luciferase
activity, suggesting that no relevant additional elements in-
volved in basal transcription are contained in this area. Fur-
ther deletion from 2193 to 287 promoted a 2-fold decrease,
suggesting the presence of positive regulatory element(s) in
this area. The resulting construct (287/165), which contains
the minimal promoter elements including the TATA box, pro-
duced 10 and 18% maximal activity in H35 and HepG2 cells,
respectively.
The profile of luciferase expression in CHO cells was quite
different from that obtained in the liver-type cells (Fig. 4C).
The constructs 21405/165, 21251/165, and 2958/165 yielded
a similar luciferase activity. Therefore, as judged by the results
obtained in the hepatic cells, the region comprised between
FIG. 5. DNase I footprinting analysis of 32P-labeled MAT 5*-flanking fragments 2193 to 165 and 21251 to 2996. Double-stranded
fragments corresponding to nucleotides 2193 to 165 (A) and 21251 to 2996 (B) of the 59-flanking region of MAT gene were synthesized by PCR
with 59-32P label on either strand and digested with different amounts of DNase I in the absence (0) or presence of 10, 20, and 50 mg of rat liver
nuclear extract. Positions of protected regions are indicated by brackets, and major hypersensitive sites are marked with asterisks. Lanes G1A
represent a Maxam-Gilbert sequencing reaction in the same fragments.
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21251 and 2958 might contain tissue-specific regulatory ele-
ments that do not account for the promoter activity in CHO
cells. On the other hand, and in contrast with the pattern
observed in H35 and HepG2 cells, sequences from 2958 to
2727 and 2375 to 2195 seem to contain elements that posi-
tively regulate transcription in CHO cells.
DNase I Footprinting Analysis of MAT 59-Flanking Region—
From the results of deletion analysis, it can be concluded that
the essential elements governing MAT expression in hepatic
cells lie between nucleotides 21251 to 2958 and 2193 to 165.
To identify these potential cis-acting elements, DNase I foot-
printing analysis was performed using both DNA fragments
and nuclear proteins isolated from rat liver. As shown in Fig.
5A, five DNase I-protected areas, designated I to V, were gen-
erated on both strands within the promoter proximal region
(2193 to 165) at increasing amounts of protein. The nucleotide
sequences of these footprints are depicted in Fig. 6. Footprint I
is a large protected area that covers putative TATA box ele-
ments. The second protected region extends from 246 to 270
and includes a significant homology to an AP1 recognition site.
Footprint III shows no sequence similarity to any of the known
protein-binding sites, as revealed by a search in transcription
factor site data bases (42, 43). The region between 2150 and
296 (footprints IV and V) adjoins sequences bearing some
resemblance to several putative transcription factor binding
sites, including cAMP response element, AP1, and AP4. Inter-
estingly, this region also contains two tandem copies of the
59-GTCGAA-39 motif, which does not match any consensus
recognition site for known transcription factors.
Three prominent DNase I-protected areas and several hyper-
sensitive sites were identified upon incubation of a DNA frag-
ment extending the promoter distal region from 21251 to 2996
with liver nuclear extracts (Fig. 5B). Footprint A spans a pu-
tative NF1 binding site, and footprint B (21132 to 21155)
includes both HNF1 and HNF3 consensus sites homologies.
Footprint C presents some sequence similarity to NF1 and
MYOD recognition sites. Several DNase I-hypersensitive
bands were also detected in this promoter region, even at low
protein input (indicated with asterisks in Fig. 5B). These could
also reflect the binding of nuclear proteins, which would make
this area more accessible to the action of the DNase I.
To approach the identification of elements that could repre-
sent binding sites for liver-enriched transcription factors,
DNase I footprinting assay was also performed using nuclear
extracts from other rat tissues. As shown in Fig. 7A, incubation
of the promoter proximal region with nuclear proteins from
liver, kidney, or lung yielded similar DNase I footprints, show-
ing a minimal variation in DNase I-hypersensitive cleavage
accompanying footprint IV. It is therefore suggested that ubiq-
uitous trans-acting factors are interacting with this promoter
area. The promoter distal region exhibited a distinct DNase I
protection pattern upon incubation with the nuclear extracts
from different sources. Thus, while footprint A was detectable
with all nuclear extracts, elements B and C were clearly pro-
tected only by nuclear proteins from liver, although the former
seemed to be weakly protected by kidney extract (Fig. 7B).
These findings suggest that element A represents a binding
site for a ubiquitous transcription factor, whereas elements B
and C interact with liver-enriched factors.
Relative Contribution of Protein-binding Sites in the Distal
Promoter Region to Transcription Activity—Since the region
spanning nucleotides 21251 to 2958 appeared to be crucial for
the promoter activity in hepatic cells, we next focused on the
analysis of the functional significance of the protein binding
sites detected by footprinting in this area. For this purpose, 59
deletion mutants extending up to each footprint were carried
out; the constructs were transfected in H35 and CHO cells, and
the transcription capacity was assessed (Fig. 8). Removal of the
fragment 21251 to 21154 containing the area corresponding to
footprint C promoted a small decrease (about 20%) of luciferase
activity. However, an additional deletion of sequences corre-
sponding to element B (21154 to 21134) resulted in about a
2-fold increase in reporter gene transcription, indicating the
presence of elements that negatively influence the promoter
function. Finally, upon deleting a fragment comprising also the
footprint A, the promoter efficiency was reduced 3-fold, render-
ing a relative luciferase activity similar to that exhibited by the
deletion construct 2958/165 (Fig. 4). On the other hand, and in
agreement with the data shown in Fig. 4, no differences in
luciferase activity were detected upon transfection of these
deletion constructs in CHO cells.
Characterization of Nuclear Protein Binding to Sequences
within Footprints A and B—Since sequences residing within
footprints A and B appeared to be of major functional rele-
vance, the identity of the potential factors that interact with
these elements was explored by gel mobility shift analysis.
Double-stranded synthetic oligonucleotides (named FPA and
FPB; see “Experimental Procedures”) encompassing each of the
two DNase I footprinted sites were used as probes and incu-
bated with nuclear extracts from rat liver and H35 cells. To
assess the specificity of each protein binding site, a series of
double-stranded oligonucleotides was used as competitors in
the binding reactions.
As shown in Fig. 9, the radiolabeled FPA probe formed two
closely spaced DNA-protein complexes with rat liver and H35
nuclear extracts. The specificity of DNA binding was estab-
lished by the ability of a 50-fold molar excess of the same
unlabeled probe to compete for complex formation. An NF1
consensus oligonucleotide efficiently competed, even better
than the homologous FPA, for binding with both nuclear ex-
tracts, whereas no competition was observed with oligonucleo-
tides containing HNF-1, HNF-3, C/EBP, or AP1 consensus
sequences. This result suggests that the protein forming these
complexes is a member of the NF1 family or an NF1-like
protein.
FIG. 6. Nucleotide sequences protected from DNase I diges-
tion. Sequences protected against DNase I digestion by hepatic nuclear
proteins are indicated by bars above (coding strand) and below (non-
coding strand). A and B represent MAT promoter proximal and distal
regions, respectively.
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Footprint B displays sequence homology to consensus bind-
ing sites for the liver-enriched factors HNF-1 and HNF-3. Ac-
cordingly, competition experiments were carried out using un-
labeled oligonucleotides corresponding to binding sequences for
these factors, as well as for C/EBP. Two major gel shift com-
plexes were detected when the FPB probe was incubated with
nuclear extracts from rat liver; the upper one fully competed by
a 50-fold molar excess of the unlabeled oligonucleotide (Fig.
10). Addition of a mutant form of FPB sequence (MtFPB) or a
C/EBP consensus element failed to compete with protein bind-
ing. However, an HNF-3 oligonucleotide markedly reduced the
complex formation. This was also competed, although to a
lesser extent, by an HNF-1 consensus binding site. Nuclear
extracts from H35 cells formed a different pattern of shifted
complexes when incubated with radiolabeled FPB. Thus, one
complex of similar electrophoretic mobility to the major com-
plex formed with rat liver extracts was detected, as well as an
additional complex of slower mobility. Both shifted bands could
be abolished by addition of excess unlabeled probe but not by
the mutated FPB sequence or C/EBP consensus element. The
formation of the upper complex was abolished by an excess of
HNF-1 oligonucleotide, which also showed a weak cross-com-
petition with the lower complex. Conversely, addition of an
HNF-3 consensus sequence did not affect the formation of the
upper complex but efficiently competed with the lower complex.
In fact, the latter exhibited a similar behavior in competition
experiments with both cell extracts. In summary, these results
suggest that in both cell extracts MAT promoter FPB element
is interacting with an HNF3-like protein, whereas in the H35
extracts, the same element also binds an HNF1-like factor.
DISCUSSION
Among mammalian tissues, the liver is a major site of pro-
duction of MAT, needed to metabolize most of the methionine
taken from the diet and to provide key metabolites for the cell.
The crucial role of the liver-specific MAT (1, 5, 44, 45) requires
a precise regulation of its expression under basal conditions
and in response to different stimuli. In this study, we report the
cloning and initial characterization of the 59-flanking region of
the rat hepatic MAT gene, providing insights into the mecha-
nisms that regulate its expression.
The gene for the rat liver-specific MAT is present as a single
copy in the genome, as has also been reported for its human
(10) and mouse (32) counterparts. The major start site of tran-
scription was determined to be 29 nucleotides downstream of
the putative TATA sequence, at the same site as that for the
mouse MAT gene (32), further supporting the assignation of
this nucleotide as the cap site. However, unlike the mouse
gene, this site corresponds to a T residue, a nucleotide not
usually found at the transcription start site in the eukaryotic
promoters analyzed (33).
Functional analysis by transient transfections has shown
that the promoter for the rat hepatic MAT is active not only in
liver-type cells but also in a non-hepatic cell such as CHO. This
finding raises the possibility that the liver-restricted expres-
sion of the endogenous gene is not mediated by the action of
tissue-specific transcription factors. In such cases, the lack of
its expression in the extrahepatic tissues could be due to situ-
ations known to stably repress the transcription of many tis-
sue-specific genes, such as DNA methylation or genome orga-
nization (i.e. compaction of the chromatin) (46, 47). By
analyzing a series of 59-end deletions, two major regulatory
regions have been identified, a promoter proximal region (2193
bp relative to the transcription start site) and a far upstream
area extending nucleotides 21251 to 2958. Most notably, pro-
moter elements located in the latter produced the highest re-
porter activity upon transfection in H35 or HepG2 cells.
It is interesting to note that major differences can be found
when the functional analysis of the 59-flanking region of rat
liver MAT gene is compared with that reported for its mouse
counterpart, despite the high sequence conservation in the
1113-bp overlapping regions. Basically, in the mouse promoter,
the 59 cis-acting elements that produce the highest transcrip-
tional activity are located between nucleotides 2365 to 2145,
and a negatively acting region has been identified between
2518 to 2366 (32). Nevertheless, it is not known whether the
crucial distal elements found in the rat promoter are also
present in its mouse counterpart, since in the latter this region
has not been analyzed.
The promoter proximal region of rat hepatic MAT appears to
contain positive elements commonly active in both hepatic-type
and CHO cells. Thus, the region spanning positions 287 to 165
exhibited similar relative transcriptional activity in the three
FIG. 7. DNase I footprinting analysis of MAT promoter using
liver and non-liver nuclear extracts. DNA fragments comprising
nucleotides 2193 to 165 (A) and 21251 to 2996 (B) of the 59-flanking
region of MAT gene were incubated with 50 mg of nuclear extracts from
the indicated tissues. Probes were labeled on the upper strand. After
DNase I digestion, samples were resolved on sequencing gels. Lane 2,
no extract added; lane G1A, Maxam-Gilbert reaction. Protected regions
are boxed.
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cell lines tested, probably owing to the action of basic regula-
tory sequences such as TATA box. In fact, three protected
elements, one of them covering the putative TATA box, were
detected in this DNA fragment by using the in vitro footprint-
ing assay, and they appear to represent binding sites for ubiq-
uitous trans-acting factors, as judged by analysis with nuclear
extracts from different sources. Two additional footprinted ar-
eas were found between nucleotides 2193 and 287. These
elements also seem to be of functional relevance since its dele-
tion produced a significant decrease in promoter activity. The
identity of the proteins binding to this proximal region is the
subject of further investigation.
The distal region is crucial for basal and tissue-specific pro-
moter activity. Thus, its removal led to a drastic reduction in
the reporter activity upon transfection in H35 and HepG2 cells
but had no effect in CHO cells. The structure-function relation-
ship of this area was studied by a combination of DNase I
footprinting analysis, transient transfections, and gel shift as-
says. With this approach, three relevant cis-acting elements
(A–C) were defined. Sequences spanning sites A and C bind
factors that positively regulate transcription of MAT promoter,
with a predominant role for site A. Gel retardation and com-
petition experiments have provided evidence that this element
interacts with a member of the NF1 family, a finding that is
consistent with the initial identification by sequence homolo-
gies. Our results suggest that NF1, which usually acts as a
positive transcription factor (30, 48), plays a key role in direct-
ing MAT expression.
On the other hand, site B appears to bind a factor that
negatively modulates transcriptional activity in H35 cells. Sur-
prisingly, an oligonucleotide containing this element showed,
in gel shift assays, different specific interactions with nuclear
extracts from rat liver and hepatoma H35 cells. Thus, it was
able to recognize a protein present in both cell extracts that, as
judged by competition experiments, appears to be a member of
the liver-enriched transcription factor HNF-3 family. However,
an additional binding activity, corresponding to a potential
HNF-1 transcription factor, was detected with the H35 extract.
It is interesting to note that site B contains the sequence
59-CGTATTGATTAAC-39, which is 90 and 84% identical to the
consensus HNF-3 (49) and HNF-1 (27) binding elements, re-
spectively. Therefore, both factors could be partially interact-
ing with the same core sequence. This assumption is supported
by the fact that a mutated form of element B disrupting this
sequence was unable to compete with the wild-type probe for
the formation of both protein complexes. The absence of HNF-1
binding activity in the liver extract is, however, difficult to
explain, since hepatic tissue expresses high levels of this tran-
scription factor (50, 51). One possible explanation derives from
the fact that de-differentiated hepatoma cells do not express
HNF-1 but present a protein called variant HNF-1 (vHNF-1 or
HNF1b, Refs. 52 and 53). Although both factors can interact
with the same target elements, it has been suggested that the
sequence of the binding site may modulate the affinities of
HNF-1 proteins, thus providing another level of regulation
(54). Therefore, vHNF-1 or a related protein present in hepa-
toma cells might somehow display a higher affinity for element
FIG. 8. Role of distal cis-acting elements in the transcriptional activity of hepatic MAT promoter. Rat hepatoma H35 and CHO cells
were transiently transfected with the indicated MAT promoter-luciferase constructs. Luciferase activities are expressed as a percentage of the
activity of the 21251/165 construct. Data are the mean 6 S.E. from three independent experiments performed in duplicate. Boxes represent the
three DNase I-footprinted regions.
FIG. 9. Gel mobility shift assay of nuclear proteins interacting
with the FPA sequence proteins binding to the MAT promoter
FPA sequence. Labeled oligonucleotide probe corresponding to DNase
I-footprinted region A was incubated with 5 mg of nuclear extracts from
rat liver or rat hepatoma H35 cells. For specific competition, a 50-fold
molar excess of unlabeled oligonucleotide corresponding to binding sites
for HNF-1, HNF-3, c/EBP, NF1, and AP1 were used (see “Experimental
Procedures” for the sequences of the oligonucleotides). The binding
reactions were separated by electrophoresis in a native 6% polyacryl-
amide gel. DNA-protein complexes are indicated by arrowheads. FIG. 10. Differential binding of nuclear proteins from rat liver
and H35 cells to the FPB sequence. Gel shift analysis of the inter-
actions of FPA with rat liver and H35 nuclear proteins. Competition
was carried out with a 50-fold molar excess of the indicated unlabeled
oligonucleotides. An FPB mutant (MtFPB; see “Experimental Proce-
dures”) was included as competitor. Arrowheads indicate the specific
binding complexes.
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B than HNF-1 and then compete with HNF-3 binding. The
finding that element B negatively regulates MAT transcription
is in agreement with this hypothesis, since HNF1 is a positive
regulatory factor (50, 51), and vHNF-1 has been shown to be
involved in the negative regulation of some liver-specific genes
(55). In this context, it should be mentioned that steady-state
levels of liver-specific MAT mRNA are lower in rat hepatoma
H35 cells than in hepatocytes (15). A similar pattern of reduced
expression has been also detected for the human hepatic
mRNA in the hepatoma HepG2 cell line,2 a finding that does
not completely agree with a previous report suggesting a com-
plete lack of transcription of the liver MAT gene in these cells
(13).
It is well documented that the successful expression of sev-
eral liver-specific genes requires a combined action of ubiqui-
tous factors, such as NF-1, and liver-enriched factors (50, 51,
56, 57). HNF-3 proteins function as transcriptional activators
(58), and their cooperative interaction with NF-1 has been
reported to be needed, among others, for the hepatocyte-specific
expression of albumin gene (59) or for full activity of the pro-
moter of C4b binding protein (60). A combined action of both
factors might also account for the proper expression of rat liver
MAT. In fact, their respective sequence elements are tandemly
arrayed and separated by only 16 nucleotides. Therefore, the
finding that in hepatoma cells an additional protein can inter-
act with the HNF-3 element of MAT promoter raises the pos-
sibility that such binding could interfere with the transactiva-
tion ability of this transcription factor. In this line, the results
presented here could explain the different basal expression of
MAT in rat liver and hepatoma cells and provide more insights
into the mechanisms governing the expression of liver-specific
genes in differentiation.
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